Promoter structure and transcriptional regulation of human β-galactoside α2, 3-sialyltransferase genes

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Six human β-galactoside α2,3-sialyltransferase genes, which are hST3Gal I-VI, have been cloned. Multiple genes encode enzymes with closely related catalytic specificities but different patterns of tissue expression. The multiple genes correspond to the control of various tissue specific regulators. Several studies have examined the transcriptional regulation of some human β-galactoside α2,3-sialyltransferases genes. Multiple mRNA forms differing only in the 5′-untranslated regions have been identified in hST3Gal II, hST3Gal III, hST3Gal IV, hST3Gal V, and hST3Gal VI. These transcripts are produced by a combination of alternative splicing and promoter utilization, suggesting the transcriptional regulation of this gene depends on the use of alternative promoters, further suggesting that tissue-specific transcriptional regulation of these genes depends on the use of multiple genes and multiple promoters. The multiple regulatory pathways of these ubiquitous sialyltransferases may be differentially modulated in various cell types.

Original languageEnglish
Pages (from-to)310-316
Number of pages7
JournalCurrent Drug Targets
Volume9
Issue number4
DOIs
Publication statusPublished - 2008 Apr
Externally publishedYes

Fingerprint

Sialyltransferases
Galactosides
Genes
Tissue
5' Untranslated Regions
Alternative Splicing
Messenger RNA
Enzymes

Keywords

  • Multiple gene
  • Multiple promoter
  • Promoter
  • Sialyltransferase

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmaceutical Science

Cite this

Promoter structure and transcriptional regulation of human β-galactoside α2, 3-sialyltransferase genes. / Taniguchi, Akiyoshi.

In: Current Drug Targets, Vol. 9, No. 4, 04.2008, p. 310-316.

Research output: Contribution to journalArticle

@article{9b0765a7c1f54c3e9df20486332684c7,
title = "Promoter structure and transcriptional regulation of human β-galactoside α2, 3-sialyltransferase genes",
abstract = "Six human β-galactoside α2,3-sialyltransferase genes, which are hST3Gal I-VI, have been cloned. Multiple genes encode enzymes with closely related catalytic specificities but different patterns of tissue expression. The multiple genes correspond to the control of various tissue specific regulators. Several studies have examined the transcriptional regulation of some human β-galactoside α2,3-sialyltransferases genes. Multiple mRNA forms differing only in the 5′-untranslated regions have been identified in hST3Gal II, hST3Gal III, hST3Gal IV, hST3Gal V, and hST3Gal VI. These transcripts are produced by a combination of alternative splicing and promoter utilization, suggesting the transcriptional regulation of this gene depends on the use of alternative promoters, further suggesting that tissue-specific transcriptional regulation of these genes depends on the use of multiple genes and multiple promoters. The multiple regulatory pathways of these ubiquitous sialyltransferases may be differentially modulated in various cell types.",
keywords = "Multiple gene, Multiple promoter, Promoter, Sialyltransferase",
author = "Akiyoshi Taniguchi",
year = "2008",
month = "4",
doi = "10.2174/138945008783954998",
language = "English",
volume = "9",
pages = "310--316",
journal = "Current Drug Targets",
issn = "1389-4501",
publisher = "Bentham Science Publishers B.V.",
number = "4",

}

TY - JOUR

T1 - Promoter structure and transcriptional regulation of human β-galactoside α2, 3-sialyltransferase genes

AU - Taniguchi, Akiyoshi

PY - 2008/4

Y1 - 2008/4

N2 - Six human β-galactoside α2,3-sialyltransferase genes, which are hST3Gal I-VI, have been cloned. Multiple genes encode enzymes with closely related catalytic specificities but different patterns of tissue expression. The multiple genes correspond to the control of various tissue specific regulators. Several studies have examined the transcriptional regulation of some human β-galactoside α2,3-sialyltransferases genes. Multiple mRNA forms differing only in the 5′-untranslated regions have been identified in hST3Gal II, hST3Gal III, hST3Gal IV, hST3Gal V, and hST3Gal VI. These transcripts are produced by a combination of alternative splicing and promoter utilization, suggesting the transcriptional regulation of this gene depends on the use of alternative promoters, further suggesting that tissue-specific transcriptional regulation of these genes depends on the use of multiple genes and multiple promoters. The multiple regulatory pathways of these ubiquitous sialyltransferases may be differentially modulated in various cell types.

AB - Six human β-galactoside α2,3-sialyltransferase genes, which are hST3Gal I-VI, have been cloned. Multiple genes encode enzymes with closely related catalytic specificities but different patterns of tissue expression. The multiple genes correspond to the control of various tissue specific regulators. Several studies have examined the transcriptional regulation of some human β-galactoside α2,3-sialyltransferases genes. Multiple mRNA forms differing only in the 5′-untranslated regions have been identified in hST3Gal II, hST3Gal III, hST3Gal IV, hST3Gal V, and hST3Gal VI. These transcripts are produced by a combination of alternative splicing and promoter utilization, suggesting the transcriptional regulation of this gene depends on the use of alternative promoters, further suggesting that tissue-specific transcriptional regulation of these genes depends on the use of multiple genes and multiple promoters. The multiple regulatory pathways of these ubiquitous sialyltransferases may be differentially modulated in various cell types.

KW - Multiple gene

KW - Multiple promoter

KW - Promoter

KW - Sialyltransferase

UR - http://www.scopus.com/inward/record.url?scp=42949173534&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42949173534&partnerID=8YFLogxK

U2 - 10.2174/138945008783954998

DO - 10.2174/138945008783954998

M3 - Article

C2 - 18393824

AN - SCOPUS:42949173534

VL - 9

SP - 310

EP - 316

JO - Current Drug Targets

JF - Current Drug Targets

SN - 1389-4501

IS - 4

ER -